Search results for: 'Radar R&D Portfolio Assessment and Opportunity Analysis'
- Did you mean
- radar r d portfolio assessment and opportunity analyst
- radar r d portfolio assessment ad opportunity analysis
- Related search terms
- analysis of the north american radiology image and information management systemnorth american radiology pacs and (ris(ris pacs) market
- analysis of the drug delivery devices market forecast to 2023
- analysis-of-top-30-features-of-mass-market-and-luxury-oems-in-northt-america
- analysis-of-the-ethiopian-pharmaceutical-market.html®ions=234
- analysis-of-the-ethiopian-pharmaceutical-market.html®ions=235
-
24 Apr 2023  |  North America  |  Market Research
Passenger Vehicle Radar Growth Opportunities in North America and Europe
Transformational Growth of Passenger Vehicle Radars with Rising Autonomous Levels will Lead to a Shift Toward Imaging Radars After 2025
Advanced driver assistance systems (ADAS) and autonomous vehicles (AVs) use radars as an integral part of the perception sensor suite to gather surrounding information and make logical decisions through artificial intelligence-based sensing and perception algorithms for autonomous driving features. Adaptive cruise control, automatic emergency br...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 Jan 2024  |  North America  |  Market Research
US Passenger Vehicle Original Equipment Manufacturers Advanced Driver Assistance Systems R&D Strategies, 2030
$50-billion Investments in ADAS R&D Will Increase Driver Engagement and Vehicle Safety Performance, Enhancing the End-customer Experience
A growing demand for safety and convenience features has amplified the development and adoption of advanced driver assistance systems (ADAS) and autonomous driving (AD) features in passenger vehicles. Original equipment manufacturers seek to adopt level-2-and-above features in their mass-market vehicles to gain a competitive advantage. The United S...
$2,450.00
Special Price $1,837.50 save 25 %
-
22 Jan 2015  |  North America  |  Market Research
A Product and Pipeline Analysis of the Antibacterial Drugs Market
Regulatory Approaches to Combat Microbial Resistance and Stimulate Antibiotics R&D
Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...
$3,950.00
Special Price $2,962.50 save 25 %
-
05 May 2023  |  North America  |  Market Research
US DoD 2024 Budget Assessment and Growth Opportunities
Balancing the Need for Replenishing Basic Weapons and Ammunition with Developing Next-generation Capabilities
This research service focuses on the US Department of Defense (DoD) 2024 spending requests for the research, development, test, and evaluation; procurement; and operations and maintenance categories. The analyst has segmented the budget request by the military department and 20 technology areas, including aircraft; ships; ground vehicles; and comma...
$2,450.00
Special Price $1,837.50 save 25 %
-
07 May 2024  |  North America  |  Market Research
US Defense Budget Assessment
Smaller Force Structure with New Combat Systems
This research service focuses on the US Department of Defense (DoD) 2025 spending requests for the research, development, test, and evaluation; procurement; and operations and maintenance categories. The analyst has segmented the budget request by the military department and 20 technology areas, including aircraft; ships; ground vehicles; and comma...
$2,450.00
Special Price $1,837.50 save 25 %
-
02 Sep 2024  |  North America  |  Market Research
US Defense Information Systems Agency Budget Assessment, FY2023 FY2029
Collaboration Between Defense and Commercial Companies Fosters an Innovation Culture
In this research service, Frost & Sullivan overviews the US Defense Information Systems Agency s (DISA) budget between FY2023 and FY2029. It outlines the agency s funding distribution for each account as well as a forecast with future spending estimates. It also includes an analysis of contract awards share. Additionally, the study highlights th...
$2,450.00
Special Price $2,082.50 save 15 %
-
31 Mar 2017  |  North America  |  Market Research
Global Digital Tools in Wound Assessment and Management, 2016
Digital Technologies Assisting Clinicians in Wound Assessment, Monitoring, and Management
Wound assessment and monitoring systems are devices or digital aids that enable the measurement, imaging, and documentation of wounds by providing 3D assessment of a wound with EMR software integration. With inadequate wound care resulting in various debilitating healthcare-associated infections and adding to the cost burden of patients, modern dig...
$3,000.00
Special Price $2,250.00 save 25 %
-
19 Nov 2020  |  North America  |  Market Research
Strategic Analysis of the Fiat Chrysler Automobiles and PSA Group Merger
With $170 Billion in Revenue, 8.5 Million in Vehicle Sales, $6.5 Billion in R&D Potential and $4 Billion in Synergies, the FCA-PSA Merger is Poised to Give Strong Competition to Global Automakers
The proposed merger between the Fiat Chrysler Automobiles (FCA) and the PSA Group is one of the most significant mergers among automotive original equipment manufacturers (OEMs). The merged company will be called Stellantis and will become the fourth-largest automotive OEM in terms of sales volume. This mega consolidation is driven by the need for ...
$2,450.00
Special Price $1,837.50 save 25 %
-
05 Feb 2021  |  North America  |  Market Research
Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market
Early-stage R&D and Commercial Applications Fuel the Growth Pipeline
The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Mar 2024  |  North America  |  Market Research
Global Orphan Drug Growth Opportunities
Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions
In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...
$4,950.00
Special Price $3,712.50 save 25 %